Saudi Arabia Gout Therapeutics Market Size & Outlook
Saudi Arabia gout therapeutics market, 2018-2030 (US$M)
Related Markets
Saudi Arabia gout therapeutics market highlights
- The Saudi Arabia gout therapeutics market generated a revenue of USD 16.1 million in 2023 and is expected to reach USD 22.6 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
- In terms of segment, nsaids was the largest revenue generating drug class in 2023.
- Urate lowering agents is the most lucrative drug class segment registering the fastest growth during the forecast period.
Gout therapeutics market data book summary
| Market revenue in 2023 | USD 16.1 million |
| Market revenue in 2030 | USD 22.6 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | Nsaids |
| Fastest growing segment | Urate lowering agents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | NSAIDs, Corticosteroids (Prednisone), Colchicine, Urate lowering agents |
| Key market players worldwide | Takeda Pharmaceutical Co Ltd, Novartis AG ADR, Regeneron Pharmaceuticals Inc, AstraZeneca PLC, Horizons International, Merck & Co Inc, Teijin Ltd, GlaxoSmithKline, Zydus Lifesciences |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.6% of the global gout therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa gout therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 17.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gout Therapeutics Market Scope
Gout Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia gout therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gout therapeutics market will help companies and investors design strategic landscapes.
Nsaids was the largest segment with a revenue share of 42.86% in 2023. Horizon Databook has segmented the Saudi Arabia gout therapeutics market based on nsaids, corticosteroids (prednisone), colchicine, urate lowering agents covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Saudi Arabia gout therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia gout therapeutics market databook
-
Our clientele includes a mix of gout therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia gout therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia gout therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia gout therapeutics market size, by drug class, 2018-2030 (US$M)
Saudi Arabia Gout Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
